Title: Michael G Agadjanyan - Innovator in Cancer Treatment
Introduction
Michael G Agadjanyan is an inventor based in Huntington Beach, CA (US). He is currently associated with Uni Vax, where he focuses on developing innovative methods for cancer treatment. Despite having no granted patents, his work is significant in the field of immunotherapy.
Latest Patent Applications
Michael G Agadjanyan has filed several notable patent applications. One of his latest applications is titled "Method for the Cancer Treatment and Prevention of Metastatic Disease." This disclosure provides a method of new use of an immunomodulatory drug comprising a water-soluble acidic peptidoglycan from sprouts of the plant (WSPG) for the prevention and treatment of metastatic tumor growth. It involves the application of a therapeutically effective dose of the immunomodulatory drug or a pharmaceutical composition with a pharmaceutically acceptable carrier or excipient. Additionally, it includes a pharmaceutically effective amount of mammalian immune cells treated with the immunomodulatory drug WSPG in vitro/ex vivo to a patient in need thereof.
Another significant application is "Exosome Mediated Innate and Adaptive Immune Stimulation for Treatment of Cancer." This disclosure outlines means of stimulating innate and/or adaptive immunity to cancer by administering exosomes. The stimulation of innate immunity involves modifying exosomes by the chemical addition of innate immune stimulators. In contrast, the stimulation of adaptive immunity involves pulsing dendritic cells generating exosomes with antigens, including pulsing with Brother of the Regulator of Imprinted Sites (BORIS) proteins, peptides, or altered peptide ligands thereof.
Conclusion
Michael G Agadjanyan is a dedicated inventor whose work in cancer treatment through innovative methods shows promise for future advancements in immunotherapy. His latest patent applications reflect his commitment to improving patient outcomes in the fight against cancer.